These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21770253)

  • 1. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of atherosclerosis: can molecular imaging do more?
    Lairez O; Fayad ZA
    Arch Cardiovasc Dis; 2013 Nov; 106(11):551-3. PubMed ID: 23927996
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
    Liu XS; Xu JR
    Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?
    Kanwar RK; Chaudhary R; Tsuzuki T; Kanwar JR
    Nanomedicine (Lond); 2012 Jun; 7(6):899-916. PubMed ID: 22715913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression.
    Millon A; Canet-Soulas E; Boussel L; Fayad Z; Douek P
    Vascular; 2014 Jun; 22(3):221-37. PubMed ID: 24907292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory medicine for molecular imaging of atherosclerosis.
    Mangge H; Almer G; Stelzer I; Reininghaus E; Prassl R
    Clin Chim Acta; 2014 Nov; 437():19-24. PubMed ID: 25003647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of atheroslerotic plaque with nuclear medicine techniques.
    Schillaci O; Danieli R; Padovano F; Testa A; Simonetti G
    Int J Mol Med; 2008 Jul; 22(1):3-7. PubMed ID: 18575769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.
    Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.
    Saam T; Hatsukami TS; Takaya N; Chu B; Underhill H; Kerwin WS; Cai J; Ferguson MS; Yuan C
    Radiology; 2007 Jul; 244(1):64-77. PubMed ID: 17581895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Applications of molecular imaging in vulnerable atherosclerotic plaque].
    Li ML; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):248-52. PubMed ID: 19507609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability.
    Kataoka Y; Nicholls SJ
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1471-89. PubMed ID: 25355677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness.
    Douma K; Megens RT; van Zandvoort MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):376-88. PubMed ID: 21448988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging.
    Lipinski MJ; Fuster V; Fisher EA; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):48-55. PubMed ID: 16265260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.